Skip to main content
  • Nederlands
    • English
    • Français

Home
  • Inloggen
  • Therapeutische domeinen
    • Cardiologie
      • ASCVD
      • Hartfalen
    • Dermatologie
      • Netelroos
    • Hematologie
      • ITP
    • Luchtwegen
    • Neurologie
      • Multiple sclerose
    • Oncologie
      • Borstkanker
      • Prostate Cancer (mCRPC)
    • Oogheelkunde
      • Netvliesaandoeningen
    • Reumatologie
  • Congressen en evenementen
    • Cardiologie
      • BSC
      • ESC
    • Dermatologie
      • EADV
      • Sharing is Caring
    • Hematologie
      • ASH
      • EHA
      • ESH
    • Neurologie
      • CMSC
      • EAN
      • ECTRIMS
    • Oncologie
      • ASCO
      • EBCC
      • ESMO
      • SABCS
    • Reumatologie
      • Sharing is Caring
  • Contact

Popular Search

  • improved
  • improving
  • aimovig
  • migration
  • migraine

Recent News

IMPACT event: Innovation and Multidisciplinary care with Pluvicto for Advanced mCRPC patients
Page protected by password
Netelroos - Doe the test
Search
Did you mean: provide?
  • Indications - Entresto

    ENTRESTO ® is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction. ENTRESTO is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic...

    Twitter Linkedin Facebook Pinterest Google plus
  • Indications - Cosentyx PsA

    Cosentyx (generic name: secukinumab) is a medication used to treat several autoimmune conditions. Here are the key indications for Cosentyx:

    1. Plaque Psoriasis:

    For adults with moderate to severe...

    Twitter Linkedin Facebook Pinterest Google plus

Filter by specialisme:

Volg Novartis

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
Sitemap
Cookie Settings
©2025 Novartis België en Luxemburg
  • Gebruiksvoorwaarden
  • Over cookies
Deze website is bestemd voor zorgverleners in België en Luxemburg